7765 Exploring the Synergistic Effect of GHRH Receptor Agonist MR-409 and Incretin-based Therapies in Type 1 Diabetes Using a Low-dose Streptozotocin Model

Abstract Disclosure: M. Gonzalez Medina: None. R. Louzada: None. V. Pita-Grisanti: None. M. Blandino: None. T. Cui: None. W. Sha: Owner/Co-Owner; Self; WS. is co-inventor on GHRH agonists MR-409 patent, assigned to the University of Miami and the Veterans Affairs. R. Cai: Owner/Co-Owner; Self; R.C....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the Endocrine Society 2024-10, Vol.8 (Supplement_1)
Hauptverfasser:	Medina, Marel Gonzalez, Louzada, Ruy, Pita-Grisanti, Valentina, Blandino, Manuel, Cui, Tengjiao, Sha, Wei, Cai, Renzhi, Schally, Andrew V, Bernal-Mizrachi, Ernesto
Format:	Artikel
Sprache:	eng
Schlagworte:	Abstract
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!